Top Markets
#1 MowCat MowCat +365.77%
#2 Islamic Coin Islamic Coin +152.17%
#3 龙虾 (Lobster) 龙虾 (Lobster) +56.26%
#4 SODAX SODAX +54.53%
#5 Cortex Cortex +32.35%
#6 BNB Attestation Service BNB Attestation Service +25.37%
#7 DexNet DexNet +23.20%
#8 OpenEden OpenEden +19.04%
#9 Pons Pons +18.25%
#10 Akedo Akedo +17.84%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Inner Mongolia Furui Medical Science Co., Ltd. Inner Mongolia Furui Medical Science Co., Ltd.

Inner Mongolia Furui Medical Science Co., Ltd.

300049
Rank in Stocks #7380
Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated... Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.
Share Price
$6.08
Market Cap
$1.61B
Change (1 day)
-0.71%
Change (1 year)
-33.05%
Country
CN
Trade Inner Mongolia Furui Medical Science Co., Ltd. (300049)

Category

Healthcare
Revenue for Inner Mongolia Furui Medical Science Co., Ltd. (300049)
Revenue in Aug 2026 TTM: 0
According to Inner Mongolia Furui Medical Science Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Inner Mongolia Furui Medical Science Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH